期刊文献+

生化标志物联合检测对急性冠脉综合征早期诊断的意义 被引量:2

Joint detection of biochemical markers in early diagnosis of acute coronary syndrome
下载PDF
导出
摘要 目的:探讨生化标志物联合检测在急性冠脉综合征(acute coronary syndromes,ACS)的早期诊断价值。方法:因胸痛发作3 h内就诊患者分为ACS组和非缺血性胸痛(non-ischemic chest pain,NICP)组,在胸痛0~3 h和3~6 h分别抽血采用ELISA等方法检测骨髓相关蛋白(Myeloid-re-lated protein,MRP)、妊娠相关蛋白A(pregnancy-associatedplasma protein A,PAPP-A)、肌酸激酶同工酶MB(creatine ki-nase-MB,CK-MB)和肌钙蛋白I(cardiac troponin I,cTnI)四项指标。评价MRP与PAPP-A、CK-MB、cTnI联合检测在ACS的早期诊断价值。结果:MRP诊断发病3 h内ACS的灵敏度为57.4%,高于PAPP-A(8.2%)、CK-MB(21.3%)和cTnI(18.0%)。四项指标联合诊断ACS的灵敏度提高到75.4%。MRP诊断发病3~6 h ACS的灵敏度为78.7%,也高于PAPP-A(39.3%)、CK-MB(49.2%)和cTnI(45.9%)。四项指标联合诊断ACS的灵敏度提高到96.7%。结论:MRP对ACS诊断的灵敏度高于PAPP-A、CK-MB、cTnI,可作为诊断ACS的早期生化标志物。四项指标联合检测可提高ACS的早期诊断。 Objective:To investigate the value of combined detection of biochemical markers in the early diagnosis of acute coronary syndrome(ACS).Methods: Eighty-one patients were divided into group ACS(patients paid hospital visit within 3 hours of the acute chest pain) and non-ischemic chest pain(NICP).Blood samples were obtained respectively during pain attack of 0 to 3h and 3h to 6h,and detected for myeloid-related protein(MRP),pregnancy-associated plasma protein A(PAPP-A),creatine kinase MB(CK-MB) and cardiac troponin I(cTnI) by ELISA to estimate the diagnostic value of the four biochemical markers in ACS.Results: MRP sensitivity for ACS within 3 hours of attack was 57.4% compared to 8.2% of PAPP-A,21.3% of CK-MB and 18.0% of cTnI.Combined biochemical markers of the four could identify 75.4% of ACS.Sensitivity of MRP for ACS between the attack of 3 to 6 hours was 78.7% compared to 39.3% of PAPP-A,49.2% of CK-MB and 45.9% of cTnI,Yet,when the four biochemical markers were in joint consideration,accurate diagnosis of ACS could be 96.7%.Conclusion: Although single marker of MRP may be more sensitive compared with PAPP-A,CK-MB and cTnI,combined detection of the four biochemical markers can be of greater importance in early diagnosis of ACS.
出处 《皖南医学院学报》 CAS 2011年第5期365-367,共3页 Journal of Wannan Medical College
基金 安徽省教育厅基金重点项目(KJ2009A181)
关键词 生化标志物 急性冠脉综合征 诊断 biochemical markers acute coronary syndrome diagnosis
  • 相关文献

参考文献9

  • 1HYATTSVILLE M,NOURJAH P.National hospital ambulatory medical care survey:1997 emergency department summary.Advance data from vital and health statistics[R].National Center for Health Statistics,2001.
  • 2POPE JH,AUFDERHEIDE TP,RUTHAZER R,et al.Missed diagnoses of acute cardiacischemia in the emergency department[J].New Engl J Med,2000,342 (16):1163-1170.
  • 3BERTRAND ME,SIMOONS MNL,FOX KAA,et al.Management of acute coronary syndromes in patients presenting without petsistents ST segment elevation.The Task Force on the Management of Acute Coronary Syndromes of the Europeans Society of Cardiology[J].Eur Heart J,2002,23(5):1809-1814.
  • 4STEJSKAL D,LACNAK B,JURAKORA R,et al.Firat experience with the cobalt binding capacity(ACB) test in the diagnosis of acute coronary syndrome[J].Vnitr Lek,2004,50 (10):734-736.
  • 5胡大一,崔亮,魏妤,陈方,王乐丰,赵文淑,顼志敏,吴雅枫,李田昌,贾三庆,杨明,王明生,陈瑾,王红石.直接经皮冠状动脉腔内成形术与溶栓治疗急性心肌梗塞近期疗效分析[J].中华心血管病杂志,1998,26(6):420-422. 被引量:102
  • 6KARRAS DJ.Serum markers in the emergency department diagnosis of acute myocardial infarction[J].Emerg Med Clin North Am,2001,19(2):321-337.
  • 7SINHA MK,ROY D,GAZE DC,et al.Role of “ischemia modified Albumin”,a new biochemical marker of myocardial ischemia,in the early diagnosis of acute coronary syndromes[J].Emerg Med J,2004,21 (1):29-34.
  • 8AHB WU,GIBLER WB,JESSE RL,et al.National Academy of Clinical Biochemistry standards of laboratory practice:recommendations for the use of cardiac markers in coronary artery diseases[J].Clin Chem,1999,45(6):1104-1121.
  • 9ALTWEGG LA,NEIDHART M,HERSBERGER M,et al.Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion:a novel,early,and sensitive marker of acute coronary syndromes[J].Eur Heart J,2007,28(3):941-948.

二级参考文献1

  • 1团体著者,中华心血管病杂志,1996年,24卷,328页

共引文献101

同被引文献24

  • 1Ravasi T,Hsu K,Goyette J,et al.Probing the S100 protein familythrough genomic and functional analysis[J].Genomics,2004,84(1):10-22.
  • 2Skubitz KM,Christiansen NP,Mendiola JR.Preparation and char-acterization of monoclonal antibodies to human neutrophil cathepsinG,lactoferrin,eosinophil peroxidase,and eosinophil major basicprotein[J].J Leukoc Biol,1989,46(2):109-118.
  • 3Zimmer DB,Cornwall EH,Landar A,et al.The S100 proteinfamily:history,function,and expression[J].Brain Res Bull,1995,37(4):417-429.
  • 4Hogg N,Allen C,Edgeworth J.Monoclonal antibody 5.5 reactswith p8,14,a myeloid molecule associated with some vascularendothelium[J].Eur J Immunol,989,19(16):1053-1061.
  • 5Hessian PA,Edqeworth J,Hoqq N.MRP-8 and MRP-14,two abun-dant Ca2+-binding proteins of neutrophils and monocytes[J].JLeukoc Biol,993,53(2):197-204.
  • 6Edqeworth J,Gorman M,Bennett R,et al.Identification of p8,14 asa highly abundant heterodimeric calcium binding protein complex ofmyeloid cells[J].J Biol Chem,1991,266(12):7706-7713.
  • 7Stroncek DF,Shankar RA,Skubitz KM.The subcellular distribu-tion of myeloid-related protein 8(MRP8)and MRP14 in humanneutrophils[J].J Transl Med,2005,3:36.
  • 8Healy AM,Pickard MD,Pradhan AD,et al.Platelet expression pro-filing and clinical validation of myeloid-related protein-14 as anovel determinant of cardiovascular events[J].Circulation,2006,113(19):2278-2284.
  • 9Vora AN,Bonaca MP,Ruff CT,et al.Diagnostic evaluation of theMRP8/14 for the emergency assessmen of chest pain[J].J ThrombThrombolysis,2012,34(2):229-234.
  • 10Loser K,Vogl T,Voskort M,et al.The toll-like receptor 4 ligandsMrp8 and Mrp14 are crucial in the development of autoreactiveCD8+T cells[J].Nat Med,2010,16(6):713-717.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部